LCM
CLLS

Logan Capital Management’s Cellectis CLLS Stock Holding History

Logan Capital Management’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-500
Closed -$10K – 524
2021
Q1 		$10K Buy
+500
New +$12.4K ﹤0.01% 429

Other funds holding CLLS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return

Logan Capital Management's CLLS Position: Q2 2021 in Review

Logan Capital Management sold out of Cellectis (CLLS) in Q2 2021, closing a stake of 500 shares — an estimated $10K sold.

Logan Capital Management first reported a position in CLLS in Q1 2021 and held it in 1 quarter. The position peaked at $10K in Q1 2021. 78 funds tracked by Wall St. Rank hold CLLS as of Q2 2021.

  • Logan Capital Management reported no remaining Cellectis position as of Q2 2021 after selling out during the quarter.
  • Logan Capital Management sold 500 Cellectis shares in Q2 2021, an estimated $10K.
  • Logan Capital Management first reported a position in Cellectis in Q1 2021 and held it in 1 quarter.
  • Logan Capital Management's Cellectis position peaked at $10K in Q1 2021.
  • 78 funds tracked by Wall St. Rank held Cellectis as of Q2 2021.

Based on Logan Capital Management's 13F filing for Q2 2021, filed 17 Aug 2021.